Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis

Abstract

The hepatic microRNA (miRNA), miR-122, is the most abundant miRNA within the liver, where it accounts for 70% of the total miRNA pool. It is known that miR-122, as an unusual host factor, increases the abundance of hepatitis C virus (HCV) RNA in HCV infection by binding directly to the 5'-UTR of the viral genome. Therefore, it has been suggested as a potential target for the treatment of hepatitis C. However, recent evidence shows that miR-122 decreases HBV replication through the inhibitory effect of p53 on HBV transcription, and consequently it acts as a tumor-suppressor through both a decrease in HBV replication and by directly targeting cyclin G1, as well as Wnt/beta-catenin, and NDRG3 pathways. This paper will briefly discuss the underlying mechanisms for the dual role of miR-122 in viral hepatitis, and explains why therapeutic applications of miR-122 may differ based on the underlying disease.

DOI: 10.5812/hepatmon.6128

Extracted Key Phrases

050010002014201520162017
Citations per Year

711 Citations

Semantic Scholar estimates that this publication has 711 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@inproceedings{Sendi2012DualRO, title={Dual Role of miR-122 in Molecular Pathogenesis of Viral Hepatitis}, author={Hossein Sendi}, booktitle={Hepatitis monthly}, year={2012} }